Generated by AI
Accuray Incorporated is a medical device company that develops, manufactures, sells, and supports advanced radiation therapy systems for cancer treatment. The company’s portfolio centers on the CyberKnife and Radixact platforms, which are designed to deliver precise, image-guided treatments for tumors and other complex clinical cases. Accuray also provides treatment planning software, motion management tools, and service offerings that support hospitals, cancer centers, and academic medical institutions. Its products are used across radiation oncology, stereotactic radiosurgery, and other specialized treatment workflows, giving the company a role in the broader market for precision oncology technologies. Accuray Incorporated focuses on combining hardware, software, and clinical support to help healthcare providers deliver targeted radiation therapy with greater accuracy and flexibility.
Website1240 Deming Way
Madison, WI, 53717-1954
United States
The latest articles about ARAY.
Accuray (ARAY) stock surged 42% premarket following a strategic CyberKnife imaging partnership with Samsung NeuroLogica.
Summary of Nov 9's posts. Generated by AI.
Summary of Sep 29's posts. Generated by AI.
Summary of Apr 30's posts. Generated by AI.
Summary of Oct 6's posts. Generated by AI.
Investors talking about ARAY also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.